Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
Jack Burks,1 Thomas S Marshall,2 Xiaolan Ye2 1Nova Southeastern University, Davie, FL, 2AbbVie Inc, Chicago, IL, USA Purpose: To evaluate adherence to disease-modifying therapies (DMTs) among patients with multiple sclerosis (MS) initiating oral and injectable DMTs, and to estimate the impact of adh...
Main Authors: | Burks J, Marshall TS, Ye X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-04-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/adherence-to-disease-modifying-therapies-and-its-impact-on-relapse-hea-peer-reviewed-article-CEOR |
Similar Items
-
Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies
by: Kay, Kathleen Alexandra
Published: (2016) -
Investigação de alcaloides ß-carbolinas, Triptaminas presentes na Ayahuasca (Santo Daime) em amostras de suor
by: Lidiane Silva Tavares
Published: (2014) -
Investigação de alcaloides ß-carbolinas, Triptaminas presentes na Ayahuasca (Santo Daime) em amostras de suor
by: Tavares, Lidiane Silva
Published: (2014) -
Multiple sclerosis patients and COVID-19
by: Hubert Mado, et al.
Published: (2021-03-01) -
Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry
by: Tamela Stuchiner, et al.
Published: (2020-12-01)